Evaluation of Efficacy and Safety of the Fixed-dose Combination of Coumarin and Troxerutin (Venalot) Versus Placebo in the Symptomatic Treatment of Chronic Venous Insufficiency - VENACT.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Coumarin/troxerutin (Primary)
- Indications Venous insufficiency
- Focus Therapeutic Use
- Acronyms VENACT
- 11 Nov 2016 Biomarkers information updated
- 13 May 2013 New trial record